Watermark

BGB-43395-302

Not yet recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-43395-302

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2025-523960-19-00

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents